Durham

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Heart failure3 trials
• High blood pressure3 trials
• Pulmonary arterial hypertension3 trials

Phase

• Phase 33 trials

Status

• Active, not recruiting2 trials
• Enrolling by invitation1 trial

Lead sponsor

• Tenax Therapeutics, Inc.3 trials

Running trials

• Enrolling by invitation

  Long-Term Open-Label Extension Study of Oral Levosimendan

  NCT07436689· Phase 3· Tenax Therapeutics, Inc.· Source

• Active, not recruiting

  LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

  NCT07288398· Phase 3· Tenax Therapeutics, Inc.· Source

• Active, not recruiting

  LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

  NCT05983250· Phase 3· Tenax Therapeutics, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting
• High blood pressure1 recruiting
• Pulmonary arterial hypertension1 recruiting